Form 8-K - Current report:
SEC Accession No. 0001773427-25-000008
Filing Date
2025-02-20
Accepted
2025-02-20 06:48:38
Documents
15
Period of Report
2025-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K swtx-20250220.htm   iXBRL 8-K 29677
2 EX-99.1 q42024-earningsrelease.htm EX-99.1 72490
6 GRAPHIC springworkslogojpeg.jpg GRAPHIC 8674
  Complete submission text file 0001773427-25-000008.txt   248567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20250220.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20250220_lab.xml EX-101.LAB 21601
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20250220_pre.xml EX-101.PRE 12512
17 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20250220_htm.xml XML 2929
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 25643201
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)